Zhang S, Lloveras V, Lope-Piedrafita S, Calero-Pérez P, Wu S, Candiota AP, Vidal-Gancedo J. Metal-Free Radical Dendrimers as MRI Contrast Agents for Glioblastoma Diagnosis: Ex Vivo and In Vivo Approaches. Biomacromolecules. 2022 Jul 11;23(7):2767-2777. doi: 10.1021/acs.biomac.2c00088. Epub 2022 Jun 24. PMID: 35749573; PMCID: PMC9277593.
Candiota AP, Arús C. Establishing Imaging Biomarkers of Host Immune System Efficacy during Glioblastoma Therapy Response: Challenges, Obstacles and Future Perspectives. Metabolites. 2022 Mar 14;12(3):243. doi: 10.3390/metabo12030243. PMID: 35323686; PMCID: PMC8950145.
Mao X, Calero-Pérez P, Montpeyó D, Bruna J, Yuste VJ, Candiota AP, Lorenzo J, Novio F, Ruiz-Molina D. Intranasal Administration of Catechol-Based Pt(IV) Coordination Polymer Nanoparticles for Glioblastoma Therapy. Nanomaterials (Basel). 2022 Apr 5;12(7):1221. doi: 10.3390/nano12071221. PMID: 35407338; PMCID: PMC9003391.
Mao X, Wu S, Calero-Pérez P, Candiota AP, Alfonso P, Bruna J, Yuste VJ, Lorenzo J, Novio F, Ruiz-Molina D. Synthesis and Validation of a Bioinspired Catechol-Functionalized Pt(IV) Prodrug for Preclinical Intranasal Glioblastoma Treatment. Cancers (Basel). 2022 Jan 14;14(2):410. doi: 10.3390/cancers14020410. PMID: 35053575; PMCID: PMC8774041.
Ruiz-Molina D, Mao X, Alfonso-Triguero P, Lorenzo J, Bruna J, Yuste VJ, Candiota AP, Novio F. Advances in Preclinical/Clinical Glioblastoma Treatment: Can Nanoparticles Be of Help? Cancers (Basel). 2022 Oct 10;14(19):4960. doi: 10.3390/cancers14194960. PMID: 36230883; PMCID: PMC9563739.
Hernández-Villegas Y, Ortega-Martorell S, Arús C, Vellido A, Julià-Sapé M. Extraction of artefactual MRS patterns from a large database using non-negative matrix factorization. NMR Biomed. 2022 Apr;35(4):e4193. doi: 10.1002/nbm.4193. Epub 2019 Dec 2. PMID: 31793715.
